Document is current
Any future updates will be listed below
-
Authors
Rantanen, Taina
Saajanaho, Milla
Karavirta, Laura
Siltanen, Sini
Rantakokko, Merja
Viljanen, Anne
Rantalainen, Timo
Pynnönen, Katja
Karvonen, Anu
Lisko, Inna
Palmberg, Lotta
Eronen, Johanna
Palonen, Eeva-Maija
Hinrichs, Timo
Kauppinen, Markku
Kokko, Katja
Portegijs, Erja https://orcid.org/0000-0002-5205-9616
-
Funding
Funding for this research was provided by:
European Research Council (693045)
Terveyden Tutkimuksen Toimikunta (310526)
- License Information
-
More Information
Article History
Received: 20 February 2018
Accepted: 19 April 2018
First Online: 2 May 2018
Ethics approval and consent to participate
: The ethical committee of the Central Finland Health Care District provided an ethical statement on the AGNES study protocol on August 23, 2017. The study includes no invasive or potentially physically or psychologically harmful elements beyond what one might experience in everyday life. Participants are asked to sign a written informed consent form at the beginning of the home interview. Participants are allowed to withdraw their consent at any time during the study or for any individual part of the study. The AGNES study follows the principles of the Declaration of Helsinki.
: Schiller AG (Baar, Switzerland) has provided two device to measure arterial stiffness for the duration of the data collection. They have no role in design and execution of the study, and will not have a role in analyses and interpretation of data, or decision to submit results. The authors declare that they have no other competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
